News for hackers. Stuff that matters.
Re:FDA Warning Letter to 23andMe by VMG on Monday November 25, 2013 @10:58AM (#6794739)
> Wallets are incredibly poor judges of medical efficacy.

So are bureaucrats who are subject to the influence of lobbyists. Snake-oil salesmen and peddlers of alternative medicine do sell their stuff under the current system, while true innovation is crushed, as is evident in this case.

Re:FDA Warning Letter to 23andMe by aroch on Monday November 25, 2013 @11:01AM (#6794768)
23&me isn't particularly innovative...They just took existing genotyping and made it available to everyone in pretty graphs
Re:FDA Warning Letter to 23andMe by VMG on Monday November 25, 2013 @11:10AM (#6794861)
Care to share a link to a competitor?
Re:FDA Warning Letter to 23andMe by aroch on Monday November 25, 2013 @11:43AM (#6795114)
Any hospital offering primary care has a lab at their disposal that can do this. Genotyping is nothing new...but as for competitors in 23&me's area (aka public access genotyping for cheap an that I can remember off the top of my head): deCODEme, lumigenix, Dna Genotek and MapMyGenome
Re:FDA Warning Letter to 23andMe by dragonwriter on Monday November 25, 2013 @01:26PM (#6795825)
Navigenics, with Navigenics Health Compass, was a competitor to 23andMe with their PGS offering, but Navigenics appears to have discontinued the competing offering (Navigenics was received initial contact from the FDA at about their product at the same time 23andMe did, they also went through similar rounds with the State of California for licensing to operate their before that.)

There's a number of other offerings that have been made in the same general space, as well.